hemoregulatory peptide 5b has been researched along with Germinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aakvaag, A; Frostad, S; Kalland, T; Laerum, OD | 1 |
| Anzenberger, G; Heinz, R; Karlic, H; Louda, N; Mühlberger, H; Paukovits, J; Pfeilstöcker, M; Pittermann, E; Salamon, J; Strobl, H | 1 |
2 other study(ies) available for hemoregulatory peptide 5b and Germinoblastoma
| Article | Year |
|---|---|
Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Colony-Forming Units Assay; Female; Glioblastoma; Glioma; Hematopoietic Stem Cells; Interleukin-3; Lymphocyte Activation; Lymphocyte Subsets; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasms; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1993 |
In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cytokines; Dimerization; Drug Synergism; Granulocyte Colony-Stimulating Factor; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Hematopoiesis; Hematopoietic Stem Cells; Heterotrimeric GTP-Binding Proteins; Humans; Interleukin-11; Interleukin-3; Interleukin-6; Lymphoma; Neoplasm Proteins; Neoplastic Stem Cells; Oligopeptides; Pyrrolidonecarboxylic Acid; RNA, Messenger; Salvage Therapy; Stem Cell Factor; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 1999 |